Skip to main content

Table 6 Locoregional recurrence within HR-/HER2- subtype by lymph node status (Number = 94).

From: Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy

Variable Locoregional recurrence No recurrence LRR probability at 60 month P-value
Node positive 5 14 23.4%  
Node negative 5 70 7.8% 0.01
  1. HER2, HER2, human epidermal growth receptor 2; HR, hormone receptor; LRR, locoregional recurrence.